Dr. Youssef S. Rizk, DO

Dr. Rizk practices at Vascular And Endovascular Institute Of Michigan in Clinton Twp, Michigan.

Dr. Rizk's NPI, 1720080385, was assigned on August 12, 2005. Dr. Rizk holds Michigan license YR022887.

Dr. Rizk's primary practice is Vascular and Endovascular Institute of Michigan, at 42855 Garfield Rd, Clinton Twp, MI 48038. The practice phone is (586) 228-3180.

Dr. Rizk's primary practice is Vascular And Endovascular Institute Of Michigan in Clinton Twp, Michigan. Dr. Rizk is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Vascular and Endovascular Institute of Michigan. Dmand AI also links Dr. Rizk to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizk practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rizk's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Rizk is licensed in Michigan.

CMS data shows 1,822 Medicare services from Dr. Rizk across 19 procedure codes in 2024, for 967 Medicare patients. Medicare paid $187,008 for them.

CMS counts 967 Medicare patients who saw Dr. Rizk in 2024. The largest group is 75 to 84, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizk's median patient age at 72, with 45% women.

In 2024, Dr. Rizk wrote 410 Medicare Part D claims for 142 patients. 90% of them were for generic drugs. CMS names the drug for 373 of them, across 7 drugs with 11 or more claims each, at $45,268 in total drug cost. In 2023, CMS named 368 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rizk for performance year 2024, reported as part of a group. Dr. Rizk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of leg revascularization (restoring blood flow) by Dr. Rizk, more than 80% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Rizk, published from 2012 to 2016. Dr. Rizk's most frequent co-authors are Sachinder S. Hans, MD, Paul G. Bove, MD and Otto William Brown, MD.

CMS Open Payments shows 29 general payments to Dr. Rizk from 12 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 83% of the total. AngioDynamics, Inc. paid the most, $4,667.